ROIV

20.56

3.56% -0.76

Pre-mercato: 20.50 -0.06 -0.29%

Roivant Sciences Ltd (ROIV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ROIV Giù? Forum Previsione

Precedente Chiudi:

$21.32

Aprire:

$21.07

Volume 24 ore:

8.08M

Relative Volume:

1.01

Capitalizzazione di mercato:

$14.04B

Reddito:

$125.68M

Utile/perdita netta:

$4.81B

Rapporto P/E:

3.6389

EPS:

5.65

Flusso di cassa netto:

$-781.21M

1 W Prestazione:

-0.05%

1M Prestazione:

+26.84%

6M Prestazione:

+91.08%

1 anno Prestazione:

+72.05%

Intervallo 1D:

$20.54

$21.23

Intervallo di 1 settimana:

$19.79

$21.35

Portata 52W:

$8.73

$21.35

Roivant Sciences Ltd Stock (ROIV) Company Profile

Nome

Roivant Sciences Ltd

Settore

Healthcare (1103)

Industria

Biotechnology (618)

Telefono

441-295-5950

Indirizzo

7TH FLOOR, 50 BROADWAY, LONDON

Dipendente

750

Cinguettio

Prossima data di guadagno

2025-02-10

Ultimi documenti SEC

ROIV's Discussions on Twitter

Confronta ROIV con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ROIV Roivant Sciences Ltd	20.56	14.83B	125.68M	4.81B	-781.21M	5.65
VRTX Vertex Pharmaceuticals Inc	434.52	110.16B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	694.99	71.65B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	453.97	59.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	891.73	54.79B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	368.36	41.77B	4.98B	69.59M	525.67M	0.5197

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-02	Iniziato	Citigroup	Buy
2025-07-10	Ripresa	Goldman	Buy
2024-02-15	Iniziato	Wolfe Research	Outperform
2024-01-05	Iniziato	Piper Sandler	Overweight
2023-12-12	Iniziato	Deutsche Bank	Buy
2023-10-17	Iniziato	Guggenheim	Buy
2023-06-08	Iniziato	BofA Securities	Neutral
2022-10-27	Iniziato	JP Morgan	Overweight
2022-05-23	Iniziato	SVB Leerink	Outperform
2022-04-29	Iniziato	Cantor Fitzgerald	Overweight
2021-12-15	Iniziato	Goldman	Buy
2021-11-08	Iniziato	H.C. Wainwright	Buy
2021-10-28	Iniziato	Citigroup	Buy
2021-10-26	Iniziato	Cowen	Outperform
2021-10-26	Iniziato	Jefferies	Buy
2021-10-26	Iniziato	Truist	Buy

Mostra tutto

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

05:51 AM

Guggenheim raises Roivant Sciences stock price target to $25 on pipeline progress - Investing.com India

05:51 AM

04:44 AM

Is Roivant Sciences Ltd. (87S) stock a momentum leaderOptions Play & Low Volatility Stock Recommendations - newser.com

04:44 AM

04:11 AM

Best data tools to analyze Roivant Sciences Ltd. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com

04:11 AM

04:06 AM

How to forecast Roivant Sciences Ltd. trends using time seriesPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com

04:06 AM

04:04 AM

Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com

04:04 AM

02:26 AM

Can Roivant Sciences Ltd. (87S) stock resist broad market declinesDip Buying & Fast Gain Stock Tips - newser.com

02:26 AM

Nov 13, 2025

Real time breakdown of Roivant Sciences Ltd. stock performanceBull Run & Smart Allocation Stock Tips - newser.com

Nov 13, 2025

Roivant Sciences: Brepocitinib And Roadmap Still Underpriced (NASDAQ:ROIV) - Seeking Alpha

Nov 13, 2025

Can Roivant Sciences Ltd. rally from current levelsJobs Report & Daily Momentum Trading Reports - newser.com

Nov 13, 2025

Roivant Sciences (ROIV): Evaluating Valuation After Earnings, Pipeline Wins, and Legal Milestone - simplywall.st

Nov 13, 2025

Nov 12, 2025

Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com

Nov 12, 2025

Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date - Markets Mojo

Nov 12, 2025

Nov 11, 2025

Citigroup Maintains Roivant Sciences (ROIV) Buy Recommendation - Nasdaq

Nov 11, 2025

Looking Into Roivant Sciences Ltd's Recent Short Interest - Benzinga

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus - Investing.com India

Nov 11, 2025

Transcript : Roivant Sciences Ltd. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-11-2025 08 - MarketScreener

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus By Investing.com - Investing.com Australia

Nov 11, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2026 Earnings Call Transcript - Insider Monkey

Nov 11, 2025

Will Roivant Sciences Ltd. stock gain from government policies2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com

Nov 11, 2025

ROIV Crosses Above Average Analyst Target - Nasdaq

Nov 11, 2025

Leerink Partners raises Roivant Sciences stock price target to $29 on model extension - Investing.com Australia

Nov 11, 2025